Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Core Evidence|January 12, 2011
Anidulafungin: an evidence-based review of its use in invasive fungal infectionsSusan L Davis, Jose A Vazquez
Pharmacotherapy|July 2, 2019
Comparison of Neutropenia Associated with Ceftaroline or Ceftriaxone in Patients Receiving at Least 7 Days of Therapy for Severe InfectionsMichael P Veve, Misa Stuart, Susan L Davis
Pharmacotherapy|October 5, 2017
Trowels and Tribulations: Review of Antimicrobial-Impregnated Bone Cements in Prosthetic Joint SurgeryVasilios Athans, Michael P Veve, Susan L Davis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2005
Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumoniaSusan L Davis, George Delgado, Peggy S McKinnon
The Annals of Pharmacotherapy|March 22, 2007
Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patientsSusan L Davis, Jose A Vazquez, Peggy S McKinnon
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 23, 2010
Implementation of a care bundle for antimicrobial stewardshipNicole R Toth, Rachel M Chambers, Susan L Davis
The Journal of Antimicrobial Chemotherapy|August 18, 2016
Outpatient use of ceftaroline fosamil versus vancomycin for osteoarticular infection: a matched cohort studyVasilios Athans, Rachel M Kenney, Jacob Wong, et al.
Infectious Diseases and Therapy|August 20, 2014
Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving VancomycinJoseph J Carreno, Anthony Jaworski, Rachel M Kenney, et al.
Journal of Pharmacy Practice|July 11, 2020
Influence of Body Weight Category on Outcomes in Candidemia Patients Treated With AnidulafunginMary Hutton, Rachel M Kenney, Jose A Vazquez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targetsRavina Kullar, Susan L Davis, Donald P Levine, et al.
Pageof 10